Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Reviewα-Methyl-5-hydroxytryptamine maleate
Description: 5-HT2B agonist
Purity: ≥98% (HPLC)
Biological Activity
5-HT2B receptor selective agonist with pKi values of 8.4, 6.1 and 7.3 at 5-HT2B, 5-HT2A and 5-HT2C receptors respectively.
Technical Data
| M. Wt | 306.32 |
| Formula | C11H14N2O.C4H4O4 |
| Storage | Store at -20°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 97469-12-0 |
| PubChem ID | 9922558 |
| InChI Key | YQNHFSXRABPJLP-BTJKTKAUSA-N |
| Smiles | OC(=O)\C=C/C(O)=O.CC(N)CC1=CNC2=C1C=C(O)C=C2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets
References
References are publications that support the biological activity of the product.
Baxter et al (1995) 5-HT2 receptor subtypes: a family re-united? TiPS 16 105 PMID: 7792930
Richardson et al (1985) Identification of serotonin M-receptor sub-types and their specific blockade by a new class of drugs. Nature 316 126 PMID: 3839291
Wilson et al (1990) 5-Hydroxytryptamine3 receptors mediate tachycardia in conscious instrumented dogs. J.Pharmacol.Exp.Ther. 252 683 PMID: 1968974
View Related Products by Target
View Related Products by Product Action
Keywords: alpha-Methyl-5-hydroxytryptamine maleate, alpha-Methyl-5-hydroxytryptamine maleate supplier, 5-HT2B, agonists, Serotonin, Receptors, 5-HT2, α-methyl-5-HT, alpha-methyl-5-HT, a-Me-5-HT, α-Methyl-5-hydroxytryptamine, alpha-Methyl-5-hydroxytryptamine, a-methyl-5-HT, α-Me-5-HT, alpha-Me-5-HT, alphamethyl, αmethyl, amethyl, 0557, Tocris Bioscience
4 Citations for α-Methyl-5-hydroxytryptamine maleate
Citations are publications that use Tocris products. Selected citations for α-Methyl-5-hydroxytryptamine maleate include:
Athilingam et al (2017) Serotonin enhances excitability and gamma frequency temporal integration in mouse prefrontal fast-spiking interneurons. Elife 6 PMID: 29206101
Nguyen et al (2019) Potentiation of the glycine response by serotonin on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice. Korean J Physiol Pharmacol 23 271 PMID: 31297011
Majeed et al (2016) Modulatory Action by the Serotonergic System: Behavior and Neurophysiology in Drosophila melanogaster. Neural Plast 2016 7291438 PMID: 26989517
Coulon et al (2011) Activity Modes in Thalamocortical Relay Neurons are Modulated by G(q)/G(11) Family G-proteins - Serotonergic and Glutamatergic Signaling. Front Cell Neurosci 4 132 PMID: 21267426
Reviews for α-Methyl-5-hydroxytryptamine maleate
There are currently no reviews for this product. Be the first to review α-Methyl-5-hydroxytryptamine maleate and earn rewards!
Have you used α-Methyl-5-hydroxytryptamine maleate?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
5-HT Receptors Scientific Review
Written by Nicholas M. Barnes and John F. Neumaier, this review summarizes the various serotonin receptor subtypes and their importance in mediating the role of serotonin in numerous physiological and pharmacological processes. Compounds available from Tocris are listed.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.